54 substances should be contraindicated, KFDA says

The Korea Food and Drug Administration announced on November 2 that it designated a total of 54 ingredients that cannot co-administered with others during doctor’s prescription or that has safety problems and age limitations, as part of efforts to promote patient safety by an increased review and awareness of outpatient prescribed drugs.

These drugs to be contraindicated during concomitant a...